Erbitux Safety Questions, Erbitux Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about Erbitux side effects. Our extensive database of Erbitux adverse events and Erbitux warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Help Community - Post Your Side Effect
Ask Our Doctors about Erbitux
Erbitux Safety Reports
Total Erbitux reports: 670.Erbitux FDA safety alerts: 2005 .
Reported deaths: 108 Reported hospitalizations: 430.
Take Erbitux Side Effects Survey or Share Your Erbitux Story.
Reported Erbitux Side Effects: dehydration, dyspnoea, infusion related reaction, nausea, vomiting, malignant neoplasm progression, diarrhoea, hypotension, mucosal inflammation, pyrexia, pneumonia aspiration.
More About Erbitux.
Showing 1-50 of 670 Next >
Erbitux Side Effects Report #5252475-6Consumer or non-health professional from UNITED STATES reported ERBITUX problem on Nov 29, 2006. Male patient, 54 years of age, weighting 127.9 lb, was diagnosed with nasal sinus cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: extravasation. ERBITUX dosage: unknown. During the same period patient was treated with VENTOLIN, NEXIUM, SYNTHROID, METOPROLOL SUCCINATE, HYDROCODONE WITH TYLENOL, TYLENOL W. Patient recovered.
Erbitux Side Effects Report #5252479-3
ERBITUX problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 12, 2007. Female patient, 48 years of age, weighting 183.0 lb, was diagnosed with colon cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: hypomagnesaemia. ERBITUX dosage: unknown. During the same period patient was treated with NEXIUM, COUMADIN, VALTREX, POTASSIUM ACETATE, ALOXI, DECADRON. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5252481-1
Consumer or non-health professional from UNITED STATES reported ERBITUX problem on Dec 07, 2006. Female patient, 58 years of age, weighting 112.4 lb, was diagnosed with colorectal cancer metastatic and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: rash. ERBITUX dosage: unknown. During the same period patient was treated with ATIVAN, IMODIUM, PREDNISONE. Patient recovered.
Erbitux Side Effects Report #5252484-7
ERBITUX problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 06, 2006. Female patient, 73 years of age, was treated with ERBITUX. ERBITUX dosage: unknown. During the same period patient was treated with CISPLATIN, CHLORIDE, BENADRYL, DECADRON, ATIVAN. Patient died.
Erbitux Side Effects Report #5252485-9
Consumer or non-health professional from UNITED STATES reported ERBITUX problem on Dec 13, 2006. Male patient, 64 years of age, was diagnosed with neoplasm malignant and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression. ERBITUX dosage: unknown. Patient died.
Erbitux Side Effects Report #5252491-4
ERBITUX problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 18, 2006. Female patient, 58 years of age, weighting 154.3 lb, was diagnosed with colorectal cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: rash. ERBITUX dosage: unknown. During the same period patient was treated with IRINOTECAN, KYTRIL, DECADRON, BENADRYL. Patient recovered.
Erbitux Side Effects Report #5252493-8
Consumer or non-health professional from UNITED STATES reported ERBITUX problem on Jan 31, 2007. Male patient, 70 years of age, was diagnosed with colorectal cancer metastatic and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, pruritus. ERBITUX dosage: unknown. During the same period patient was treated with BENADRYL. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5252496-3
ERBITUX problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 21, 2006. Female patient, 52 years of age, weighting 116.8 lb, was diagnosed with laryngeal cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: infusion site reaction. ERBITUX dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOTERE, FLUOROURACIL. Patient recovered.
Erbitux Side Effects Report #5252497-5
Consumer or non-health professional from UNITED STATES reported ERBITUX problem on Dec 26, 2006. Male patient, 70 years of age, was diagnosed with colon cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: dermatitis acneiform. ERBITUX dosage: unknown. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, LEUCOVORIN CALCIUM, AVASTIN, DECADRON, ATROPINE, BENADRYL, ASPIRIN. Patient recovered.
Erbitux Side Effects Report #5252498-7
ERBITUX problem was reported by a Health Professional from UNITED STATES on Dec 27, 2006. Male patient, 62 years of age, was diagnosed with colorectal cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: sepsis. ERBITUX dosage: unknown. During the same period patient was treated with IRINOTECAN, AVASTIN, BENADRYL. Patient was hospitalized. Patient died on 12/23/2006.
Erbitux Side Effects Report #5252501-4
Consumer or non-health professional from UNITED STATES reported ERBITUX problem on Jan 03, 2007. Female patient, 54 years of age, was diagnosed with neoplasm malignant and was treated with ERBITUX. ERBITUX dosage: unknown. Patient died.
Erbitux Side Effects Report #5252502-6
ERBITUX problem was reported by a Health Professional from UNITED STATES on Jan 23, 2007. Female patient, 52 years of age, was diagnosed with neoplasm malignant and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: hypomagnesaemia. ERBITUX dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5252503-8
Consumer or non-health professional from UNITED STATES reported ERBITUX problem on Jan 04, 2007. Male patient, 45 years of age, weighting 235.9 lb, was diagnosed with colon cancer metastatic and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: headache. ERBITUX dosage: unknown. During the same period patient was treated with RESTORIL, TRAZODONE, QVAR, ALBUTEROL, BENADRYL. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5252505-1
ERBITUX problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 04, 2007. Male patient, 49 years of age, was diagnosed with neoplasm malignant and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: hypotension, infusion related reaction, respiratory arrest. ERBITUX dosage: unknown. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5252506-3
Physician from UNITED STATES reported ERBITUX problem on Jan 26, 2007. Male patient, 64 years of age, was diagnosed with colon cancer metastatic and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: infusion related reaction. ERBITUX dosage: unknown. Patient recovered.
Erbitux Side Effects Report #5252507-5
ERBITUX problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 08, 2007. Female patient, 39 years of age, weighting 110.2 lb, was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: rash pustular. ERBITUX dosage: unknown. Patient recovered.
Erbitux Side Effects Report #5252509-9
Consumer or non-health professional from UNITED STATES reported ERBITUX problem on Jan 11, 2007. Male patient, 64 years of age, was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. ERBITUX dosage: unknown. During the same period patient was treated with BENADRYL, DEXAMETHASONE, COUMADIN, LYRICA. Patient recovered.
Erbitux Side Effects Report #5252510-5
ERBITUX problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 12, 2007. Female patient, weighting 114.6 lb, was diagnosed with non-small cell lung cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: asthenia, constipation, dyspnoea, ear pain, rash pustular, skin exfoliation, stomatitis, weight decreased. ERBITUX dosage: unknown. During the same period patient was treated with CISPLATIN, EFFEXOR, DARVOCET, IBUPROFEN, DUONEB, NEULASTA. Patient recovered.
Erbitux Side Effects Report #5252516-6
Consumer or non-health professional from UNITED STATES reported ERBITUX problem on Jan 22, 2007. Female patient, 65 years of age, was diagnosed with neoplasm malignant and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: mucosal inflammation. ERBITUX dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient recovered.
Erbitux Side Effects Report #5252518-X
ERBITUX problem was reported by a Physician from UNITED STATES on Jan 24, 2007. Male patient, 54 years of age, was diagnosed with non-small cell lung cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: anxiety, cyanosis, dyspnoea, flushing. ERBITUX dosage: unknown. During the same period patient was treated with BENADRYL, TYLENOL. Patient recovered.
Erbitux Side Effects Report #5252523-3
Physician from UNITED STATES reported ERBITUX problem on Jan 25, 2007. Male patient, 53 years of age, was diagnosed with tonsil cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, respiratory arrest. ERBITUX dosage: unknown. During the same period patient was treated with BENADRYL, DEXAMETHASONE, ZOFRAN. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5252524-5
ERBITUX problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 26, 2007. Male patient, 51 years of age, was diagnosed with neoplasm malignant and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: respiratory distress. ERBITUX dosage: unknown. During the same period patient was treated with LISINOPRIL, ATENOLOL, GLUCOPHAGE, GLIPIZIDE, ZOCOR, DIOVAN, LEXAPRO. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5254878-2
Health Professional from UNITED STATES reported ERBITUX problem on Feb 22, 2007. Female patient, 49 years of age, was diagnosed with non-small cell lung cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: diverticulum. ERBITUX dosage: unknown. During the same period patient was treated with TAXOL, CARBOPLATIN, LEUKINE. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5256242-9
ERBITUX problem was reported by a Pharmacist from UNITED STATES on Mar 02, 2007. Male patient was diagnosed with colon cancer, metastases to liver and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: cough, dyspnoea, infusion related reaction, pruritus, urticaria. ERBITUX dosage: unknown. Patient recovered.
Erbitux Side Effects Report #5256642-7
Health Professional from UNITED STATES reported ERBITUX problem on Feb 27, 2007. Male patient, 51 years of age, weighting 211.6 lb, was diagnosed with tonsil cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: cough, dehydration, dysphagia, infection, mucosal inflammation, nausea, pneumonia aspiration, vomiting. ERBITUX dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5259045-4
ERBITUX problem was reported by a Consumer or non-health professional from GERMANY on Feb 09, 2007. Male patient, 61 years of age, was diagnosed with laryngeal cancer stage ii and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: pneumonia aspiration. ERBITUX dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
Erbitux Side Effects Report #5259837-1
Consumer or non-health professional from UNITED STATES reported ERBITUX problem on Mar 07, 2007. Female patient, 59 years of age, was diagnosed with colon cancer metastatic and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. ERBITUX dosage: unknown. During the same period patient was treated with ATENOLOL, INSULIN GLARGINE, COMPAZINE. Patient recovered.
Erbitux Side Effects Report #5260843-1
ERBITUX problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2007. Male patient, 61 years of age, was diagnosed with colorectal cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: chills, meningitis bacterial. ERBITUX dosage: unknown. During the same period patient was treated with ZOMETA. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5260954-0
Health Professional from UNITED STATES reported ERBITUX problem on Mar 08, 2007. Male patient, 39 years of age, weighting 160.9 lb, was diagnosed with neoplasm malignant and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: dysphagia, mucosal inflammation. ERBITUX dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5260957-6
ERBITUX problem was reported by a Health Professional from UNITED STATES on Mar 08, 2007. Male patient, 52 years of age, weighting 158.7 lb, was diagnosed with neoplasm malignant and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: dehydration, hypomagnesaemia, nausea, vomiting. ERBITUX dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5266178-5
Health Professional from GERMANY reported ERBITUX problem on Mar 09, 2007. Female patient, 70 years of age, was diagnosed with squamous cell carcinoma and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: pneumonia aspiration. ERBITUX dosage: unknown. Patient died on 03/03/2007.
Erbitux Side Effects Report #5267246-4
ERBITUX problem was reported by a Health Professional from UNITED STATES on Mar 15, 2007. Male patient, 51 years of age, weighting 211.6 lb, was diagnosed with tonsil cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: catheter related infection, cough, dehydration, dysphagia, mucosal inflammation, nausea, pneumonia aspiration, vomiting. ERBITUX dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5268142-9
Consumer or non-health professional from UNITED STATES reported ERBITUX problem on Mar 15, 2007. Female patient, 44 years of age, weighting 183.0 lb, was diagnosed with breast cancer metastatic, chest pain, anaemia, prophylaxis, skin ulcer, hypokalaemia and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, sepsis, skin ulcer. ERBITUX dosage: unknown. During the same period patient was treated with CARBOPLATIN, IRINOTECAN, VICODIN, ARANESP, COMPAZINE, CIPRO, NEULASTA, POTASSIUM ACETATE. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5268255-1
ERBITUX problem was reported by a Health Professional from UNITED STATES on Mar 14, 2007. Male patient, 39 years of age, weighting 160.9 lb, was diagnosed with tonsil cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: dysphagia, mucosal inflammation, weight decreased. ERBITUX dosage: unknown. During the same period patient was treated with CISPLATIN, TAXOTERE, FENTANYL, OXYCODONE, GABAPENTIN, DECADRON, ZOFRAN. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5269052-3
Consumer or non-health professional from GERMANY reported ERBITUX problem on Mar 13, 2007. Female patient, 42 years of age, weighting 125.7 lb, was diagnosed with colorectal cancer metastatic and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome. ERBITUX dosage: unknown. During the same period patient was treated with MIRTAZAPINE, VENLAFAXINE, BROMAZEPAM. Patient was hospitalized and became disabled. Patient died.
Erbitux Side Effects Report #5269512-5
ERBITUX problem was reported by a Physician from GERMANY on Mar 14, 2007. Male patient, 63 years of age, was diagnosed with squamous cell carcinoma, colorectal cancer, diabetes mellitus non-insulin-dependent and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: renal failure chronic. ERBITUX dosage: unknown. During the same period patient was treated with INSULIN. Patient died.
Erbitux Side Effects Report #5269516-2
Health Professional from UNITED STATES reported ERBITUX problem on Mar 19, 2007. Male patient, 52 years of age, weighting 158.7 lb, was diagnosed with neoplasm malignant and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased, dehydration, hypomagnesaemia, nausea, vomiting. ERBITUX dosage: unknown. During the same period patient was treated with CISPLATIN, ATIVAN, DECADRON, METHADONE, OXYCODONE, SENOKOT. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5271000-7
ERBITUX problem was reported by a Consumer or non-health professional from GERMANY on Mar 13, 2007. Male patient, 70 years of age, was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: abdominal pain lower, colitis, melaena. ERBITUX dosage: unknown. During the same period patient was treated with ASPIRIN, ATENOLOL, RAMIPRIL, SIMVASTATIN. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5276650-X
Consumer or non-health professional from GERMANY reported ERBITUX problem on Mar 20, 2007. Female patient, 42 years of age, weighting 125.7 lb, was diagnosed with colorectal cancer metastatic and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome. ERBITUX dosage: unknown. During the same period patient was treated with MIRTAZAPINE, VENLAFAXINE, BROMAZEPAM, EFFEXOR, REMERON, STILNOX, ISCADOR. Patient was hospitalized and became disabled. Patient died on 09/06/2006.
Erbitux Side Effects Report #5276651-1
ERBITUX problem was reported by a Health Professional from UNITED STATES on Mar 19, 2007. Female patient, 52 years of age, was diagnosed with non-small cell lung cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, hypersensitivity. ERBITUX dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, DILAUDID, LEXAPRO, COUMADIN, ZANTAC, ESTROGENS SOL, BACLOFEN. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5276911-4
Consumer or non-health professional from UNITED STATES reported ERBITUX problem on Mar 22, 2007. Male patient, 48 years of age, was diagnosed with neoplasm malignant and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: leg amputation, thrombosis. ERBITUX dosage: unknown. During the same period patient was treated with TYLENOL, BENADRYL. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5277224-7
ERBITUX problem was reported by a Health Professional from UNITED STATES on Mar 22, 2007. Male patient was diagnosed with neoplasm malignant and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: aphasia, blood pressure increased, dyspnoea, flushing, heart rate increased, infusion related reaction, oxygen saturation decreased. ERBITUX dosage: 100 MG -50 CC- ONE HOUR IV DRIP. Patient recovered.
Erbitux Side Effects Report #5278296-6
Consumer or non-health professional from UNITED STATES reported ERBITUX problem on Mar 27, 2007. Male patient, 61 years of age, was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: syncope, ventricular tachycardia. ERBITUX dosage: unknown. During the same period patient was treated with CISPLATIN, COUMADIN, DIGOXIN, METOPROLOL SUCCINATE. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5279977-0
ERBITUX problem was reported by a Health Professional from UNITED STATES on Mar 27, 2007. Male patient, weighting 221.0 lb, was diagnosed with lung neoplasm malignant and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, fat embolism, ischaemia. ERBITUX dosage: 540MG WEEKOLY IV DRIP. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5281569-4
Consumer or non-health professional from UNITED STATES reported ERBITUX problem on Mar 28, 2007. Female patient, 44 years of age, weighting 183.0 lb, was diagnosed with breast cancer metastatic, chest pain, anaemia, prophylaxis, skin ulcer, hypokalaemia and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, sepsis, skin ulcer. ERBITUX dosage: unknown. During the same period patient was treated with CARBOPLATIN, IRINOTECAN, VICODIN, ARANESP, COMPAZINE, CIPRO, NEULASTA, POTASSIUM ACETATE. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5281862-5
ERBITUX problem was reported by a Health Professional from GERMANY on Mar 26, 2007. Male patient, 53 years of age, was diagnosed with rectal cancer metastatic and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: dermatitis acneiform, hyperglycaemia. ERBITUX dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5284322-0
Health Professional from UNITED STATES reported ERBITUX problem on Mar 30, 2007. Male patient, weighting 221.0 lb, was diagnosed with lung neoplasm malignant and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: gangrene, toe amputation. ERBITUX dosage: 540MG WEEKLY IV. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5284487-0
ERBITUX problem was reported by a Pharmacist from UNITED STATES on Mar 30, 2007. Male patient, 55 years of age, was diagnosed with neoplasm malignant and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: meningitis aseptic. ERBITUX dosage: 400 MG/M2 -890 MG- FIRST DOSE IV. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5284808-9
Health Professional from UNITED STATES reported ERBITUX problem on Apr 02, 2007. Female patient, 73 years of age, weighting 125.7 lb, was diagnosed with breast cancer metastatic and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea. ERBITUX dosage: unknown. During the same period patient was treated with CARBOPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.
Erbitux Side Effects Report #5293130-6
ERBITUX problem was reported by a Consumer or non-health professional from GERMANY on Apr 04, 2007. Male patient, 54 years of age, was diagnosed with gastrooesophageal cancer, vitamin supplementation and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, pulmonary embolism. ERBITUX dosage: unknown. During the same period patient was treated with DOCETAXEL, VITAMIN CAP, FEFOL, NEXIUM, ENOXAPARIN. Patient was hospitalized. Patient recovered.
Showing 1-50 of 670 Next >
Drug Information: Cetuximab Injection
URL of this page: http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a607041.html
(se tux' i mab)IMPORTANT WARNING:
| Cetuximab may cause severe or life-threatening reactions while you receive the medication. These reactions are more common with the first dose of cetuximab, but may occur at any time during treatment. Your doctor will watch you carefully while you receive each dose of cetuximab and for at least one hour afterwards. Tell your doctor if you experience any of the following symptoms during or after your infusion: shortness of breath, wheezing or noisy breathing, hoarseness, hives, fainting, dizziness, blurred vision, nausea, or chest pain or pressure. If you experience a severe reaction, your doctor will stop your infusion and treat the symptoms of the reaction. You will not be able to receive treatment with cetuximab in the future. People with a head and neck cancer who are treated with radiation therapy and cetuximab may have an increased risk of cardiopulmonary arrest (condition in which the heart stops beating and breathing stops) and/or sudden death during or after their treatment. Tell your doctor if you have or have ever had coronary artery disease (condition that occurs when the blood vessels of the heart are narrowed by fat or cholesterol deposits); angina (chest pain or pressure); a heart attack; congestive heart failure; irregular heartbeat; other heart disease; or lower than normal levels of magnesium, potassium, or calcium in your blood.Keep all appointments with your doctor and the laboratory. Your doctor will order certain tests during and after your treatment to check your body's response to cetuximab.Talk to your doctor about the risks of using cetuximab. |
Why is this medication prescribed?
Cetuximab is used with or without radiation therapy to treat a certain type of cancer of the head and neck. Cetuximab is also used alone or in combination with another medication to treat a certain type of cancer of the colon (large intestine) or rectum that has spread to other parts of the body. Cetuximab has been shown to slow the growth of tumors in people who have cancer of the colon or rectum. However, it has not been shown to help people who have cancer of the colon or rectum feel better or live longer. Cetuximab is in a class of medications called monoclonal antibodies. It works by slowing or stopping the growth of cancer cells.
How should this medicine be used?
Cetuximab comes as a solution (liquid) to be infused (injected slowly) into a vein. Cetuximab is given by a doctor or nurse in a medical office or infusion center. It is usually given once a week.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before receiving treatment with cetuximab,
- tell your doctor and pharmacist if you are allergic to cetuximab, any medications that are made from murine (mouse) proteins, or any other medications. Ask your doctor or pharmacist if you don't know whether a medication that you are allergic to is made from murine proteins.
- tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention if you are receiving treatment with cisplatin (Platinol). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
- tell your doctor if you have or have ever had lung disease.
- tell your doctor if you are pregnant or plan to become pregnant. Use effective birth control to prevent pregnancy during your treatment with cetuximab. If you become pregnant while using cetuximab, call your doctor.
- tell your doctor if you are breast-feeding. You should not breastfeed during your treatment with cetuximab or for 60 days after you stop using the medication.
- plan to avoid unnecessary or prolonged exposure to sunlight and to wear protective clothing, a hat, sunglasses, and sunscreen. Cetuximab may make your skin sensitive to sunlight.
What special dietary instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
What should I do if I forget a dose?
If you miss an appointment to receive a dose of cetuximab, call your doctor right away.
What side effects can this medication cause?
Cetuximab may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- acne-like rash
- dry or cracking skin
- swelling or pain in the fingernails or toenails
- red, watery, or itchy eye(s)
- red or swollen eyelid(s)
- pain or burning sensation in eye(s)
- sensitivity of eyes to light
- hair loss
- dry mouth
- chapped lips
- mouth sores
- difficulty swallowing
- headache
- tiredness
- weakness
- difficulty falling asleep or staying asleep
- depression
- nausea
- vomiting
- constipation
- stomach pain
- heartburn
- loss of appetite
- weight loss
- pain, especially in the back
- pain, redness, or swelling at injection spot
Some side effects can be serious. If you experience any of these symptoms or those listed in the IMPORTANT WARNING section, call your doctor immediately:
- swelling of the hands, feet, ankles, or lower legs
- fast heartbeat
- coughing up blood or dry cough
- shortness of breath or unusual tiredness during exercise
- fainting
- decreased urination
- muscle cramps
- shaking of the hands that you cannot control
- sudden tightening of the hands or feet
- twitching of the body that you cannot control
- sore throat, fever, chills, and other signs of infection
- diarrhea
- confusion
- itching
- hives
- red, swollen, or infected skin
Cetuximab may cause other side effects. Call your doctor if you have any unusual problems while using this medication.
In case of emergency/overdose
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.
What other information should I know?
Ask your doctor if you have any questions about your treatment with cetuximab.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Brand name(s):
|